A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)
Clinical trial NCT02121782 · COMPLETED
Trial details
- NCT number
- NCT02121782
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.